Metabolomics

Dataset Information

0

Single Cell Spatial Analysis Reveals the Topology of Immunomodulatory Purinergic Signaling in Glioblastoma


ABSTRACT: Abstract from manuscript Glioblastoma develops an immunosuppressive microenvironment that fosters tumorigenesis and resistance to current therapeutic strategies. Here we use multiplexed tissue imaging and single-cell RNA-sequencing to characterize the composition, spatial organization, and clinical significance of extracellular purinergic signaling in glioblastoma. We show that glioblastoma exhibit strong expression of CD39 and CD73 ectoenzymes, correlating with increased adenosine levels. Microglia are the predominant source of CD39, while CD73 is principally expressed by tumor cells, particularly in tumors with amplification of EGFR and astrocyte-like differentiation. Spatially-resolved single-cell analyses demonstrate strong spatial correlation between tumor CD73 and microglial CD39, and that their spatial proximity is associated with poor clinical outcomes. Together, this data reveals that tumor CD73 expression correlates with tumor genotype, lineage differentiation, and functional states, and that core purine regulatory enzymes expressed by neoplastic and tumor-associated myeloid cells interact to promote a distinctive adenosine-rich signaling niche and immunosuppressive microenvironment potentially amenable to therapeutic targeting.

ORGANISM(S): Human Homo Sapiens

TISSUE(S): Brain

DISEASE(S): Cancer

SUBMITTER: Sylwia Stopka  

PROVIDER: ST002203 | MetabolomicsWorkbench | Mon Jun 27 00:00:00 BST 2022

REPOSITORIES: MetabolomicsWorkbench

Dataset's files

Source:
Action DRS
mwtab Other
Items per page:
1 - 1 of 1

Similar Datasets

| 2332975 | ecrin-mdr-crc
2024-11-08 | GSE247299 | GEO
2023-10-06 | GSE244825 | GEO
2024-08-01 | GSE273251 | GEO
2014-09-23 | E-GEOD-51332 | biostudies-arrayexpress
2024-08-12 | PXD041689 | Pride
2023-09-28 | GSE244190 | GEO
2023-09-24 | GSE243577 | GEO
2024-04-09 | PXD047328 | Pride
2024-06-01 | GSE266884 | GEO